Entertainment
Sirius Therapeutics to Present Data from Its Phase 1 Clinical Trial of Factor XI siRNA, a Long-Acting Potential Treatment for Thrombosis
New Hope for Thrombosis Patients: SRSD107 Shows Promise in Treating Blood Clots Exciting new data from Sirius Therapeutics suggests a potential breakthrough in the treatment
December 3, 2024
No Comments
